| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
5e-05 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0003 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
0.0007 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |